ARTICLE | Company News
InnoPharma, Pfizer deal
October 13, 2014 7:00 AM UTC
Pfizer completed its acquisition of sterile injectable company InnoPharma for $225 million in cash up front. InnoPharma is also eligible for up to $135 million in milestones (see BioCentury, July 21)....